{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:16:45Z","timestamp":1789402605825,"version":"build-2803163510"},"reference-count":328,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.intimp.2022.109040","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T02:22:41Z","timestamp":1657506161000},"page":"109040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis\/thromboinflammation"],"prefix":"10.1016","volume":"110","author":[{"given":"Seyed Shahabeddin","family":"Mortazavi-Jahromi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109040_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(21)00105-8","article-title":"COVID-19-associated coagulopathy and antithrombotic agents\u2014lessons after 1 year","author":"Leentjens","year":"2021","journal-title":"Lancet Haematol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b0010","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","article-title":"Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19","volume":"21","author":"Bonaventura","year":"2021","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0015","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/thoraxjnl-2020-216243","article-title":"COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms","volume":"76","author":"Loo","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2022.109040_b0020","first-page":"2608","article-title":"Possibilities for the Entrance of SARS-Cov-2 as an Archaeal Virus into the Ecosystem","author":"Mirshafiey","year":"2021","journal-title":"Iranian J. Public Health"},{"key":"10.1016\/j.intimp.2022.109040_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108172","article-title":"Cytokine storm in the pathophysiology of COVID-19: possible functional disturbances of miRNAs","volume":"101","author":"Aslani","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0030","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.4049\/jimmunol.2001327","article-title":"The inflammatory factors associated with disease severity to predict COVID-19 progression","volume":"206","author":"Huang","year":"2021","journal-title":"J. Immunol."},{"issue":"57","key":"10.1016\/j.intimp.2022.109040_b0035","doi-asserted-by":"crossref","first-page":"eabg9873","DOI":"10.1126\/sciimmunol.abg9873","article-title":"Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19","volume":"6","author":"Thwaites","year":"2021","journal-title":"Sci. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0040","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1136\/thoraxjnl-2020-216256","article-title":"Distinct cellular immune profiles in the airways and blood of critically ill patients with COVID-19","volume":"76","author":"Saris","year":"2021","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2022.109040_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/cbin.11623","article-title":"COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management","author":"Kohansal Vajari","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.intimp.2022.109040_b0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.thromres.2020.06.027","article-title":"Is COVID-19 associated thrombosis caused by overactivation of the complement cascade?","volume":"194","author":"Fletcher-Sandersj\u00f6\u00f6","year":"2020","journal-title":"A literature review, Thrombosis research"},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0055","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1089\/vim.2021.0042","article-title":"Levamisole Therapy in COVID-19","volume":"34","author":"Al-Kuraishy","year":"2021","journal-title":"Viral Immunol."},{"key":"10.1016\/j.intimp.2022.109040_b0060","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.thromres.2020.04.013","article-title":"Incidence of thrombotic complications in critically ill ICU patients with COVID-19","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"issue":"8","key":"10.1016\/j.intimp.2022.109040_b0065","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jth.14888","article-title":"Incidence of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Middeldorp","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2022.109040_b0070","first-page":"1","article-title":"Patients with COVID-19: in the dark-NETs of neutrophils","author":"Ackermann","year":"2021","journal-title":"Cell Death Differ."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0075","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00414-020-02317-w","article-title":"Dying with SARS-CoV-2 infection\u2014an autopsy study of the first consecutive 80 cases in Hamburg, Germany","volume":"134","author":"Edler","year":"2020","journal-title":"Int. J. Legal Med."},{"key":"10.1016\/j.intimp.2022.109040_b0080","doi-asserted-by":"crossref","DOI":"10.1177\/17590914211057635","article-title":"Covid-19-induced dysautonomia: a menace of sympathetic storm","volume":"13","author":"Al-Kuraishy","year":"2021","journal-title":"ASN neuro"},{"key":"10.1016\/j.intimp.2022.109040_b0085","doi-asserted-by":"crossref","unstructured":"H.M. Al-kuraishy, A.I. Al-Gareeb, M.S. Fageyinbo, G.E.-S. Batiha, Vinpocetine is the forthcoming adjuvant agent in the management of COVID-19, Future Sci. OA (0) (2022) FSO797.","DOI":"10.2144\/fsoa-2021-0099"},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0090","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s00210-021-02147-6","article-title":"Covid-19 and development of heart failure: mystery and truth","volume":"394","author":"Onohuean","year":"2021","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109040_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104417","article-title":"What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?","volume":"85","author":"Guterres","year":"2020","journal-title":"Infection, Genetics Evol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s12943-018-0765-5","article-title":"Nuclear functions of mammalian MicroRNAs in gene regulation, immunity and cancer","volume":"17","author":"Liu","year":"2018","journal-title":"Molecular cancer"},{"key":"10.1016\/j.intimp.2022.109040_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2020.07.008","article-title":"A comprehensive review on miR-146a molecular mechanisms in a wide spectrum of immune and non-immune inflammatory diseases","author":"Mortazavi-Jahromi","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.intimp.2022.109040_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110203","article-title":"A new approach for COVID-19 treatment by micro-RNA","volume":"143","author":"El-Nabi","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-020-01374-4","article-title":"MiR-223 plays a protecting role in neutrophilic asthmatic mice through the inhibition of NLRP3 inflammasome","volume":"21","author":"Xu","year":"2020","journal-title":"Respir. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000445625","article-title":"MiR-410 down-regulates the expression of interleukin-10 by targeting STAT3 in the pathogenesis of systemic lupus erythematosus","volume":"39","author":"Liu","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2022.109040_b0125","article-title":"Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality","volume":"108516","author":"Al-Kuraishy","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109040_b0130","first-page":"8575","article-title":"Neutrophil extracellular traps (NETs): the role of inflammation and coagulation in COVID-19","volume":"13","author":"Jing","year":"2021","journal-title":"Am. J. Translational Res."},{"key":"10.1016\/j.intimp.2022.109040_b0135","first-page":"1","article-title":"COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure","author":"Marchetti","year":"2020","journal-title":"Ann. Hematol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0140","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.3390\/ijms21041391","article-title":"P2Y12 inhibition beyond thrombosis: Effects on inflammation","volume":"21","author":"Mansour","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b0145","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1055\/s-0040-1718732","article-title":"Neutrophil\u2013platelet and monocyte\u2013platelet aggregates in COVID-19 patients","volume":"120","author":"Le Joncour","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b0150","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1182\/blood.2020007214","article-title":"Platelet gene expression and function in patients with COVID-19","volume":"136","author":"Manne","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2022.109040_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118617","article-title":"Preventing the development of severe COVID-19 by modifying immunothrombosis","volume":"264","author":"Morris","year":"2021","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0160","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/s41591-020-0901-9","article-title":"Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19","volume":"26","author":"Liao","year":"2020","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-32576-y","article-title":"Respiratory Syncytial Virus induces the classical ROS-dependent NETosis through PAD-4 and necroptosis pathways activation","volume":"8","author":"Muraro","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0175","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1128\/IAI.01104-13","article-title":"Antibodies mediate formation of neutrophil extracellular traps in the middle ear and facilitate secondary pneumococcal otitis media","volume":"82","author":"Short","year":"2014","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b0180","doi-asserted-by":"crossref","first-page":"e20201129","DOI":"10.1084\/jem.20201129","article-title":"SARS-CoV-2\u2013triggered neutrophil extracellular traps mediate COVID-19 pathology","volume":"217","author":"Veras","year":"2020","journal-title":"J. Exp. Med."},{"issue":"5663","key":"10.1016\/j.intimp.2022.109040_b0185","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0190","doi-asserted-by":"crossref","first-page":"e1000639","DOI":"10.1371\/journal.ppat.1000639","article-title":"Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans","volume":"5","author":"Urban","year":"2009","journal-title":"PLoS Pathog."},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b0195","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1084\/jem.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"Li","year":"2010","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b0200","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1038\/cdd.2009.96","article-title":"Viable neutrophils release mitochondrial DNA to form neutrophil extracellular traps","volume":"16","author":"Yousefi","year":"2009","journal-title":"Cell Death Differ."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b0205","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0210","doi-asserted-by":"crossref","first-page":"e48111","DOI":"10.1371\/journal.pone.0048111","article-title":"Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition","volume":"7","author":"Keshari","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109040_b0215","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.atherosclerosis.2017.06.226","article-title":"Arterial hypertension enhances neutrophil extracellular trap formation via an angiotensin-II-dependent pathway","volume":"263","author":"Hofbauer","year":"2017","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s42003-021-01829-4","article-title":"IFN signaling and neutrophil degranulation transcriptional signatures are induced during SARS-CoV-2 infection","volume":"4","author":"Rosa","year":"2021","journal-title":"Commun. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b0225","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nm.3547","article-title":"Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines","volume":"20","author":"Schauer","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0230","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1096\/fj.201800752R","article-title":"Aggregated neutrophil extracellular traps resolve inflammation by proteolysis of cytokines and chemokines and protection from antiproteases","volume":"33","author":"Hahn","year":"2019","journal-title":"FASEB J."},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0235","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1111\/bjh.15062","article-title":"Haemostasis and innate immunity\u2013a complementary relationship: a review of the intricate relationship between coagulation and complement pathways","volume":"180","author":"Keragala","year":"2018","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.intimp.2022.109040_b0240","doi-asserted-by":"crossref","unstructured":"J.-J. Lai, F.M. Cruz, K.L. Rock, Immune sensing of cell death through recognition of histone sequences by C-type lectin-receptor-2d causes inflammation and tissue injury, Immunity 52(1) (2020) 123-135. e6.","DOI":"10.1016\/j.immuni.2019.11.013"},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b0245","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1161\/CIRCULATIONAHA.120.048488","article-title":"Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy","volume":"142","author":"Nicolai","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0250","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1093\/infdis\/jiaa756","article-title":"Association of neutrophil activation, more than platelet activation, with thrombotic complications in coronavirus disease 2019","volume":"223","author":"Petito","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0255","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200652","article-title":"Targeting potential drivers of COVID-19: Neutrophil extracellular traps","volume":"217","author":"Barnes","year":"2020","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0260","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir. Med."},{"issue":"16","key":"10.1016\/j.intimp.2022.109040_b0265","doi-asserted-by":"crossref","first-page":"8854","DOI":"10.3390\/ijms22168854","article-title":"Neutrophil Extracellular Traps (NETs) in Severe SARS-CoV-2 Lung Disease","volume":"22","author":"Szturmowicz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b0270","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1172\/JCI141374","article-title":"Complement and tissue factor\u2013enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis","volume":"130","author":"Skendros","year":"2020","journal-title":"J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b0275","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI insight"},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0280","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1182\/blood.2020007008","article-title":"Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome","volume":"136","author":"Middleton","year":"2020","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b0285","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/ATVBAHA.120.315267","article-title":"Circulating markers of neutrophil extracellular traps are of prognostic value in patients with COVID-19","volume":"41","author":"Ng","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2022.109040_b0290","doi-asserted-by":"crossref","first-page":"102925","DOI":"10.1016\/j.ebiom.2020.102925","article-title":"Vascular occlusion by neutrophil extracellular traps in COVID-19","volume":"58","author":"Leppkes","year":"2020","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0295","first-page":"1952","article-title":"Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4","volume":"118","author":"Semeraro","year":"2011","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b0300","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/j.1538-7836.2011.04422.x","article-title":"Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation","volume":"9","author":"Ammollo","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"36","key":"10.1016\/j.intimp.2022.109040_b0305","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0310","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1136\/annrheumdis-2013-204837","article-title":"Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2","volume":"74","author":"Carmona-Rivera","year":"2015","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0315","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1161\/ATVBAHA.117.309002","article-title":"Neutrophil extracellular traps drive endothelial-to-mesenchymal transition","volume":"37","author":"Pieterse","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2022.109040_b0320","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.640842","article-title":"Vasculitis and neutrophil extracellular traps in lungs of golden Syrian hamsters with SARS-CoV-2","volume":"12","author":"Becker","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0325","first-page":"1","article-title":"Obesity-induced endothelial dysfunction is prevented by neutrophil extracellular trap inhibition","volume":"8","author":"Wang","year":"2018","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0330","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/cei.12654","article-title":"Neutrophil extracellular traps can activate alternative complement pathways","volume":"181","author":"Wang","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"45","key":"10.1016\/j.intimp.2022.109040_b0335","doi-asserted-by":"crossref","first-page":"E9618","DOI":"10.1073\/pnas.1708247114","article-title":"Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis","volume":"114","author":"Schreiber","year":"2017","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2022.109040_b0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Trans. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0345","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaci.2020.05.006","article-title":"Complement activation in patients with COVID-19: a novel therapeutic target","volume":"146","author":"Cugno","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b0350","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1111\/jth.14981","article-title":"COVID-19: a collision of complement, coagulation and inflammatory pathways","volume":"18","author":"Chauhan","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2022.109040_b0355","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.3389\/fimmu.2021.714511","article-title":"Lectin pathway mediates complement activation by SARS-CoV-2 proteins","volume":"12","author":"Ali","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109040_b0360","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767981","article-title":"SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation","volume":"12","author":"Jarlhelt","year":"2021","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0365","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.177.7.4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006","journal-title":"J. Immunol."},{"issue":"02","key":"10.1016\/j.intimp.2022.109040_b0370","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0375","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/cei.12663","article-title":"The key roles of complement and tissue factor in Escherichia coli-induced coagulation in human whole blood","volume":"182","author":"Landsem","year":"2015","journal-title":"Clin. Exp. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0380","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1172\/JCI117430","article-title":"C5a-induced expression of P-selectin in endothelial cells","volume":"94","author":"Foreman","year":"1994","journal-title":"J. Clin. Investig."},{"issue":"16","key":"10.1016\/j.intimp.2022.109040_b0385","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.118.034600","article-title":"Functional relevance of the anaphylatoxin receptor C3aR for platelet function and arterial thrombus formation marks an intersection point between innate immunity and thrombosis","volume":"138","author":"Sauter","year":"2018","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.intimp.2022.109040_b0390","first-page":"2291","article-title":"Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development","volume":"129","author":"Subramaniam","year":"2017","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.intimp.2022.109040_b0395","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1146\/annurev.immunol.23.021704.115835","article-title":"Role of C5a in inflammatory responses","volume":"23","author":"Guo","year":"2005","journal-title":"Annu. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0400","doi-asserted-by":"crossref","first-page":"e623","DOI":"10.1371\/journal.pone.0000623","article-title":"Simultaneous activation of complement and coagulation by MBL-associated serine protease 2","volume":"2","author":"Krarup","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109040_b0405","doi-asserted-by":"crossref","unstructured":"T. Wiedmer, C.T. Esmon, P.J. Sims, Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase, (1986).","DOI":"10.1182\/blood.V68.4.875.875"},{"issue":"15","key":"10.1016\/j.intimp.2022.109040_b0410","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1016\/S0021-9258(18)81901-9","article-title":"Complement proteins C5b\u20139 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface","volume":"264","author":"Hattori","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.intimp.2022.109040_b0415","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1538-7836.2006.02046.x","article-title":"The complement component C5a induces the expression of plasminogen activator inhibitor-1 in human macrophages via NF-\u03baB activation","volume":"4","author":"Kastl","year":"2006","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0420","doi-asserted-by":"crossref","first-page":"e35690","DOI":"10.1371\/journal.pone.0035690","article-title":"Effects of MASP-1 of the complement system on activation of coagulation factors and plasma clot formation","volume":"7","author":"Hess","year":"2012","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b0425","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.molimm.2014.05.013","article-title":"Multiple roles of complement MASP-1 at the interface of innate immune response and coagulation","volume":"61","author":"Dob\u00f3","year":"2014","journal-title":"Mol. Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0430","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.110.954370","article-title":"C5a receptor targeting in neointima formation after arterial injury in atherosclerosis-prone mice","volume":"122","author":"Shagdarsuren","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.intimp.2022.109040_b0435","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3389\/fimmu.2021.651545","article-title":"Immunothrombosis in Acute Respiratory Dysfunction of COVID-19","volume":"12","author":"Fang","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0440","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-80010-z","article-title":"Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients","volume":"11","author":"Zuo","year":"2021","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b0445","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1111\/jth.15016","article-title":"Hypofibrinolytic state and high thrombin generation may play a major role in SARS-COV2 associated thrombosis","volume":"18","author":"Nougier","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0450","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.bja.2020.12.010","article-title":"Impaired fibrinolysis in critically ill COVID-19 patients","volume":"126","author":"Bachler","year":"2021","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.intimp.2022.109040_b0455","first-page":"1","article-title":"The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19","author":"Onishi","year":"2022","journal-title":"Int. J. Hematol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0460","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.5858\/arpa.2020-0324-SA","article-title":"Coagulation DysfunctionA Hallmark in COVID-19","volume":"144","author":"Fei","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"5\u20136","key":"10.1016\/j.intimp.2022.109040_b0465","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000083842","article-title":"New aspects in thrombotic research: complement induced switch in mast cells from a profibrinolytic to a prothrombotic phenotype","volume":"33","author":"Wojta","year":"2003","journal-title":"Pathophysiol. Haemost. Thromb."},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b0470","doi-asserted-by":"crossref","first-page":"e26762","DOI":"10.1371\/journal.pone.0026762","article-title":"Platelets retain high levels of active plasminogen activator inhibitor 1","volume":"6","author":"Brogren","year":"2011","journal-title":"PLoS ONE"},{"issue":"36","key":"10.1016\/j.intimp.2022.109040_b0475","doi-asserted-by":"crossref","first-page":"22351","DOI":"10.1073\/pnas.2010229117","article-title":"IL-6 trans-signaling induces plasminogen activator inhibitor-1 from vascular endothelial cells in cytokine release syndrome","volume":"117","author":"Kang","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.intimp.2022.109040_b0480","doi-asserted-by":"crossref","unstructured":"H.C. Kwaan, Coronavirus disease 2019: the role of the fibrinolytic system from transmission to organ injury and sequelae, Seminars in thrombosis and hemostasis, Thieme Medical Publishers, 2020, pp. 841-844.","DOI":"10.1055\/s-0040-1709996"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0485","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/ATVBAHA.120.315338","article-title":"COVID-19 and sepsis are associated with different abnormalities in plasma procoagulant and fibrinolytic activity","volume":"41","author":"Bouck","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2022.109040_b0490","doi-asserted-by":"crossref","unstructured":"F.L. Wright, T.O. Vogler, E.E. Moore, H.B. Moore, M.V. Wohlauer, S. Urban, T.L. Nydam, P.K. Moore, R.C. McIntyre Jr, Fibrinolysis shutdown correlation with thromboembolic events in severe COVID-19 infection, Journal of the American College of Surgeons 231(2) (2020) 193-203. e1.","DOI":"10.1016\/j.jamcollsurg.2020.05.007"},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b0495","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11239-020-02226-0","article-title":"High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there?","volume":"51","author":"Iba\u00f1ez","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.intimp.2022.109040_b0500","doi-asserted-by":"crossref","unstructured":"D. Cabrera-Garcia, A. Miltiades, S. Parsons, K. Elisman, M.T. Mansouri, G. Wagener, N.L. Harrison, High levels of plasminogen activator inhibitor-1, tissue plasminogen activator and fibrinogen in patients with severe COVID-19, MedRxiv (2021) 2020.12. 29.20248869.","DOI":"10.1101\/2020.12.29.20248869"},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0505","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"issue":"8","key":"10.1016\/j.intimp.2022.109040_b0510","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1016\/S2352-3026(20)30216-7","article-title":"Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study","volume":"7","author":"Goshua","year":"2020","journal-title":"Lancet Haematol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b0515","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.3324\/haematol.2019.217463","article-title":"Platelet HIF-2\u03b1 promotes thrombogenicity through PAI-1 synthesis and extracellular vesicle release","volume":"104","author":"Chaurasia","year":"2019","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.intimp.2022.109040_b0520","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.intimp.2022.109040_b0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101069","article-title":"Upregulation of pulmonary tissue factor, loss of thrombomodulin and immunothrombosis in SARS-CoV-2 infection","volume":"39","author":"Francischetti","year":"2021","journal-title":"EClinicalMedicine"},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b0530","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1002\/phar.2465","article-title":"Coagulopathy, venous thromboembolism, and anticoagulation in patients with COVID-19","volume":"40","author":"Dobesh","year":"2020","journal-title":"Pharmacother.: J. Hum. Pharmacol. Drug Ther."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0535","first-page":"15","article-title":"Prognostic value of antithrombin levels in COVID-19 patients and impact of fresh frozen plasma treatment: a retrospective study","volume":"38","author":"Anakl\u0131","year":"2021","journal-title":"Turkish J. Hematol."},{"key":"10.1016\/j.intimp.2022.109040_b0540","doi-asserted-by":"crossref","unstructured":"G. Lippi, B.M. Henry, F. Sanchis-Gomar, Plasma antithrombin values are significantly decreased in coronavirus disease 2019 (COVID-19) patients with severe illness, Seminars in Thrombosis and Hemostasis, Thieme Medical Publishers, Inc., 2021, pp. 460-462.","DOI":"10.1055\/s-0040-1716873"},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b0545","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1055\/s-0040-1716544","article-title":"Derivation and validation of a predictive score for disease worsening in patients with COVID-19","volume":"120","author":"Gerotziafas","year":"2020","journal-title":"Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0550","doi-asserted-by":"crossref","first-page":"e0241329","DOI":"10.1371\/journal.pone.0241329","article-title":"The values of coagulation function in COVID-19 patients","volume":"15","author":"Jin","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109040_b0555","doi-asserted-by":"crossref","first-page":"e64330","DOI":"10.7554\/eLife.64330","article-title":"SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung","volume":"10","author":"Mast","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.intimp.2022.109040_b0560","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.791716","article-title":"Soluble Urokinase Plasminogen Activator Receptor (suPAR) Independently Predicts Severity and Length of Hospitalisation in Patients With COVID-19","volume":"8","author":"Enocsson","year":"2021","journal-title":"Front. Med."},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b0565","doi-asserted-by":"crossref","first-page":"474","DOI":"10.14740\/jocmr4579","article-title":"Evaluation of plasma soluble urokinase plasminogen activator receptor levels in patients with COVID-19 and non-COVID-19 pneumonia: an observational cohort study","volume":"13","author":"Velissaris","year":"2021","journal-title":"J. Clin. Med. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0570","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3390\/jcm11010134","article-title":"Elevated TAT in COVID-19 Patients with Normal D-Dimer as a Predictor of Severe Respiratory Failure: A Retrospective Analysis of 797 Patients","volume":"11","author":"Takeshita","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2022.109040_b0575","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.thromres.2021.05.016","article-title":"Low admission protein C levels are a risk factor for disease worsening and mortality in hospitalized patients with COVID-19","volume":"204","author":"Stanne","year":"2021","journal-title":"Thromb. Res."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0580","first-page":"251","article-title":"Anticoagulant protein S in COVID-19: low activity, and associated with outcome","volume":"58","author":"Stoichitoiu","year":"2020","journal-title":"Rom J Intern Med"},{"key":"10.1016\/j.intimp.2022.109040_b0585","unstructured":"J.A. Borovac, H.M. Van Beusekom, Thrombomodulin as an early marker of endotheliitis in COVID-19."},{"key":"10.1016\/j.intimp.2022.109040_b0590","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8671713","article-title":"Endothelial dysfunction, inflammation, and oxidative stress in COVID-19\u2014Mechanisms and therapeutic targets","volume":"2021","author":"Fodor","year":"2021","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0595","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/ATVBAHA.120.314860","article-title":"Endothelial dysfunction and thrombosis in patients with COVID-19\u2014brief report","volume":"40","author":"Nagashima","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0600","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-020-00454-7","article-title":"Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches","volume":"5","author":"Jin","year":"2020","journal-title":"Signal Transduction Targeted Ther."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0605","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nm1565","article-title":"Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood","volume":"13","author":"Clark","year":"2007","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b0610","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41577-020-0407-1","article-title":"Tissue damage from neutrophil-induced oxidative stress in COVID-19","volume":"20","author":"Laforge","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0615","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.micinf.2020.05.006","article-title":"Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency","volume":"22","author":"Green","year":"2020","journal-title":"Microbes Infect."},{"key":"10.1016\/j.intimp.2022.109040_b0620","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101982","article-title":"Decreased availability of nitric oxide and hydrogen sulfide is a hallmark of COVID-19","volume":"43","author":"Dominic","year":"2021","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0625","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1515\/tjb-2021-0013","article-title":"Oxidative stress index can be a new marker related to disease severity in COVID-19","volume":"46","author":"Do\u011fan","year":"2021","journal-title":"Turkish J. Biochem."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0630","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/01.ATV.0000078521.51319.65","article-title":"Angiotensin II inhibits endothelial cell motility through an AT1-dependent oxidant-sensitive decrement of nitric oxide availability","volume":"23","author":"Desideri","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0635","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00819-6","article-title":"Endothelial dysfunction contributes to severe COVID-19 in combination with dysregulated lymphocyte responses and cytokine networks","volume":"6","author":"Ruhl","year":"2021","journal-title":"Signal Transduction Targeted Ther."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0640","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/jth.14850","article-title":"Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis","volume":"18","author":"Panigada","year":"2020","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0645","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1093\/infdis\/jiaa349","article-title":"Elevated expression of serum endothelial cell adhesion molecules in COVID-19 patients","volume":"222","author":"Tong","year":"2020","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.intimp.2022.109040_b0650","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.thromres.2022.03.013","article-title":"Associations between hemostatic markers and mortality in COVID-19\u2013Compounding effects of D-dimer, antithrombin and PAP complex","volume":"213","author":"Bokn\u00e4s","year":"2022","journal-title":"Thromb. Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0655","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.intimp.2022.109040_b0660","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5620314","article-title":"The role of von Willebrand factor in vascular inflammation: from pathogenesis to targeted therapy","volume":"2017","author":"Gragnano","year":"2017","journal-title":"Mediators Inflamm."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0665","doi-asserted-by":"crossref","first-page":"e59372","DOI":"10.1371\/journal.pone.0059372","article-title":"Assembly and activation of alternative complement components on endothelial cell-anchored ultra-large von Willebrand factor links complement and hemostasis-thrombosis","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109040_b0670","doi-asserted-by":"crossref","DOI":"10.1111\/ijlh.13244","article-title":"Involvement of ADAMTS13 and von Willebrand factor in thromboembolic events in patients infected with SARS-CoV-2","author":"Huisman","year":"2020","journal-title":"Int. J. Lab. Hematol."},{"key":"10.1016\/j.intimp.2022.109040_b0675","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.thromres.2020.07.034","article-title":"A relative ADAMTS13 deficiency supports the presence of a secondary microangiopathy in COVID 19","volume":"193","author":"Martinelli","year":"2020","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0680","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.268","article-title":"Neutrophil extracellular traps and von Willebrand factor are allies that negatively influence COVID-19 outcomes","volume":"11","author":"Fern\u00e1ndez-P\u00e9rez","year":"2021","journal-title":"Clin. Translational Med."},{"key":"10.1016\/j.intimp.2022.109040_b0685","first-page":"65","article-title":"Platelets: essential components of the immune system","volume":"16","author":"Ali","year":"2015","journal-title":"Curr. Trends Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0690","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3390\/ijms21030866","article-title":"Reduced miR-26b expression in megakaryocytes and platelets contributes to elevated level of platelet activation status in sepsis","volume":"21","author":"Szil\u00e1gyi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0695","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1074-7613(03)00177-8","article-title":"Platelet-mediated modulation of adaptive immunity: a communication link between innate and adaptive immune compartments","volume":"19","author":"Elzey","year":"2003","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0700","first-page":"188","article-title":"Stable messenger RNA in the synthesis of contractile protein in human platelets, Biochimica et Biophysica Acta (BBA)-Nucleic Acids and Protein","volume":"145","author":"Booyse","year":"1967","journal-title":"Synthesis"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0705","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12959-021-00311-9","article-title":"Thrombosis in COVID-19 infection: Role of platelet activation-mediated immunity","volume":"19","author":"Fard","year":"2021","journal-title":"Thrombosis J."},{"issue":"17","key":"10.1016\/j.intimp.2022.109040_b0710","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.3390\/ijms20174185","article-title":"Role of NF-\u03baB in platelet function","volume":"20","author":"Kojok","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b0715","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.thromres.2013.11.028","article-title":"Regulation of platelet responses triggered by Toll-like receptor 2 and 4 ligands is another non-genomic role of nuclear factor-kappaB","volume":"133","author":"Rivadeneyra","year":"2014","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0720","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-020-00954-7","article-title":"SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109040_b0725","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1007\/s11010-021-04130-4","article-title":"Possible role of purinergic signaling in COVID-19","volume":"476","author":"Franciosi","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b0730","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1182\/blood.2020007252","article-title":"Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19","volume":"136","author":"Hottz","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0735","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1080\/09537104.2020.1852543","article-title":"Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure","volume":"32","author":"Campo","year":"2021","journal-title":"Platelets"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0740","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCRESAHA.112.274241","article-title":"Engagement of platelet toll-like receptor 9 by novel endogenous ligands promotes platelet hyperreactivity and thrombosis","volume":"112","author":"Panigrahi","year":"2013","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0745","doi-asserted-by":"crossref","first-page":"e41254","DOI":"10.1371\/journal.pone.0041254","article-title":"Platelet-derived Toll-like receptor 4 (Tlr-4) is sufficient to promote microvascular thrombosis in endotoxemia","volume":"7","author":"Stark","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2022.109040_b0750","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.3389\/fphar.2020.601685","article-title":"TLR9 and COVID-19: a multidisciplinary theory of a multifaceted therapeutic target","volume":"11","author":"Bezemer","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109040_b0755","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3389\/fimmu.2021.636954","article-title":"Neutrophil extracellular traps activate proinflammatory functions of human neutrophils","volume":"12","author":"D\u00f6mer","year":"2021","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b0760","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107602","article-title":"Histones, DNA, and citrullination promote neutrophil extracellular trap inflammation by regulating the localization and activation of TLR4","volume":"31","author":"Tsourouktsoglou","year":"2020","journal-title":"Cell Rep."},{"issue":"22","key":"10.1016\/j.intimp.2022.109040_b0765","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehv044","article-title":"TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion","volume":"36","author":"Quillard","year":"2015","journal-title":"Eur. Heart J."},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b0770","doi-asserted-by":"crossref","first-page":"e1002355","DOI":"10.1371\/journal.ppat.1002355","article-title":"Novel anti-bacterial activities of \u03b2-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation","volume":"7","author":"Kraemer","year":"2011","journal-title":"PLoS Pathog."},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b0775","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1111\/jth.12710","article-title":"Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps","volume":"12","author":"Maugeri","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0780","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109020","article-title":"Hypoxic and pharmacological activation of HIF inhibits SARS-CoV-2 infection of lung epithelial cells","volume":"35","author":"Wing","year":"2021","journal-title":"Cell reports"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0785","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-021-00726-w","article-title":"HIF-1\u03b1 promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19","volume":"6","author":"Tian","year":"2021","journal-title":"Signal Transduction Targeted Ther."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0790","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/07853890.2020.1858234","article-title":"Increased expression of hypoxia-induced factor 1\u03b1 mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients","volume":"53","author":"Taniguchi-Ponciano","year":"2021","journal-title":"Ann. Med."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0795","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.7150\/thno.44364","article-title":"CXCL12-mediated monocyte transmigration into brain perivascular space leads to neuroinflammation and memory deficit in neuropathic pain","volume":"11","author":"Mai","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0800","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1165\/rcmb.2015-0237OC","article-title":"Hypoxia-inducible factor-1\u03b1 regulates CD55 in airway epithelium","volume":"55","author":"Pandya","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b0805","doi-asserted-by":"crossref","first-page":"eabm1896","DOI":"10.1126\/sciadv.abm1896","article-title":"PAI-1 is a vascular cell\u2013specific HIF-2\u2013dependent angiogenic factor that promotes retinal neovascularization in diabetic patients","volume":"8","author":"Qin","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.intimp.2022.109040_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2021.07.004","article-title":"Efficient Roles of miR-146a in Cellular and Molecular Mechanisms of Neuroinflammatory Disorders: An Effectual Review in Neuroimmunology","author":"Aslani","year":"2021","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0815","doi-asserted-by":"crossref","first-page":"L405","DOI":"10.1152\/ajplung.00457.2020","article-title":"Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients","volume":"320","author":"Centa","year":"2021","journal-title":"Am. J. Physiol.-Lung Cellular Mol. Physiol."},{"issue":"19","key":"10.1016\/j.intimp.2022.109040_b0820","first-page":"5189","article-title":"Platelet microRNA-mRNA coexpression profiles correlate with platelet reactivity","volume":"117","author":"Nagalla","year":"2011","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0825","doi-asserted-by":"crossref","first-page":"dmm031708","DOI":"10.1242\/dmm.031708","article-title":"The role of the microRNA-146a\/complement factor H\/interleukin-1\u03b2-mediated inflammatory loop circuit in the perpetuate inflammation of chronic temporal lobe epilepsy","volume":"11","author":"Li","year":"2018","journal-title":"Dis. Models Mech."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b0830","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.120.314092","article-title":"Identification of a plasma MicroRNA profile associated with venous thrombosis","volume":"40","author":"Rodriguez-Rius","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0835","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1080\/09537104.2020.1775804","article-title":"MicroRNA-126 is a regulator of platelet-supported thrombin generation","volume":"31","author":"Zapilko","year":"2020","journal-title":"Platelets"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0840","first-page":"4759","article-title":"MicroRNA-146a\/NAPDH oxidase4 decreases reactive oxygen species generation and inflammation in a diabetic nephropathy model","volume":"17","author":"Wan","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0845","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/life12040575","article-title":"Profiling Levels of Serum microRNAs and Soluble ACE2 in COVID-19 Patients","volume":"12","author":"Elemam","year":"2022","journal-title":"Life"},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0850","doi-asserted-by":"crossref","first-page":"e23590","DOI":"10.1002\/jcla.23590","article-title":"Differential microRNA expression in the peripheral blood from human patients with COVID-19","volume":"34","author":"Li","year":"2020","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.intimp.2022.109040_b0855","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2021.105020","article-title":"Circulating miRNAs: Potential diagnostic role for coronavirus disease 2019 (COVID-19)","volume":"94","author":"Fayyad-Kazan","year":"2021","journal-title":"Infection, Genetics Evol."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0860","doi-asserted-by":"crossref","first-page":"e1009759","DOI":"10.1371\/journal.ppat.1009759","article-title":"Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection","volume":"17","author":"Farr","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.intimp.2022.109040_b0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107641","article-title":"Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a\u20133p, 155\u20135p, and let-7b-3p in PBMC","volume":"97","author":"Donyavi","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-021-01717-7","article-title":"Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response","volume":"18","author":"Wu","year":"2021","journal-title":"Virology J."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40001-021-00544-4","article-title":"The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization","volume":"26","author":"Keikha","year":"2021","journal-title":"Eur. J. Med. Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0880","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1515\/tjb-2020-0520","article-title":"Serum microRNA signature is capable of predictive and prognostic factor for SARS-CoV-2 virulence","volume":"46","author":"Demiray","year":"2021","journal-title":"Turkish J. Biochem."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b0885","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cvr\/cvab338","article-title":"Association of cardiometabolic microRNAs with COVID-19 severity and mortality","volume":"118","author":"Gutmann","year":"2022","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b0890","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1183\/09031936.00163414","article-title":"miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production","volume":"46","author":"Oglesby","year":"2015","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2022.109040_b0895","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3389\/fimmu.2019.02462","article-title":"MiR-155 regulates PAD4-dependent formation of neutrophil extracellular traps","volume":"10","author":"Hawez","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0900","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1189\/jlb.1012539","article-title":"The not-so-neutral role of microRNAs in neutrophil biology","volume":"94","author":"Gantier","year":"2013","journal-title":"J. Leukoc. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b0905","doi-asserted-by":"crossref","first-page":"e9024","DOI":"10.15252\/emmm.201809024","article-title":"Targeting miR-223 in neutrophils enhances the clearance of Staphylococcus aureus in infected wounds","volume":"10","author":"de Kerckhove","year":"2018","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0910","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12865-015-0134-8","article-title":"Impact of microRNA-130a on the neutrophil proteome","volume":"16","author":"Pedersen","year":"2015","journal-title":"BMC Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0915","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3324\/haematol.2019.240226","article-title":"miR-146a is a pivotal regulator of neutrophil extracellular trap formation promoting thrombosis","volume":"106","author":"Arroyo","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.intimp.2022.109040_b0920","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3389\/fphys.2021.652579","article-title":"MicroRNA as Potential Biomarkers of Platelet Function on Antiplatelet Therapy: A Review","volume":"12","author":"Czajka","year":"2021","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b0925","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.trsl.2013.06.008","article-title":"MicroRNA regulation of integrins","volume":"162","author":"Chen","year":"2013","journal-title":"Translational Res."},{"issue":"52","key":"10.1016\/j.intimp.2022.109040_b0930","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1038\/onc.2008.282","article-title":"Integrin \u03b2 3 expression is regulated by let-7a miRNA in malignant melanoma","volume":"27","author":"M\u00fcller","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.intimp.2022.109040_b0935","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fimmu.2019.01053","article-title":"The interaction between two worlds: microRNAs and Toll-like receptors","volume":"10","author":"Bayraktar","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b0940","doi-asserted-by":"crossref","first-page":"e62232","DOI":"10.1371\/journal.pone.0062232","article-title":"MicroRNA-146a is upregulated by and negatively regulates TLR2 signaling","volume":"8","author":"Quinn","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0945","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-4598-12-77","article-title":"The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells","volume":"12","author":"Guo","year":"2013","journal-title":"Mol. Cancer"},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0950","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1159\/000322105","article-title":"Regulation of NADPH oxidase activity is associated with miRNA-25-mediated NOX4 expression in experimental diabetic nephropathy","volume":"32","author":"Fu","year":"2010","journal-title":"Am. J. Nephrol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b0955","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s40495-016-0051-4","article-title":"Interplay between reactive oxygen species and microRNAs in cancer","volume":"2","author":"He","year":"2016","journal-title":"Curr. Pharmacol. Rep."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b0960","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/neurintsurg-2016-012463","article-title":"NADPH oxidase inhibitor regulates microRNAs with improved outcome after mechanical reperfusion","volume":"9","author":"Liu","year":"2017","journal-title":"J. NeuroInterventional Surg."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b0965","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pathol.2021.09.006","article-title":"Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection","volume":"54","author":"Haroun","year":"2022","journal-title":"Pathology"},{"key":"10.1016\/j.intimp.2022.109040_b0970","article-title":"A Differential Signature of Circulating miRNAs and Cytokines Between COVID-19 and Community-Acquired Pneumonia Uncovers Novel Physiopathological Mechanisms of COVID-19","volume":"12","author":"Mart\u00ednez-Fleta","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2022.109040_b0975","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111413","article-title":"Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients","volume":"193","author":"Sabbatinelli","year":"2021","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.intimp.2022.109040_b0980","article-title":"The miRNA neuroinflammatory biomarkers in COVID-19 patients with different severity of illness","author":"Keikha","year":"2021","journal-title":"Neurolog\u00eda"},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b0985","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1002\/ctm2.200","article-title":"The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19","volume":"10","author":"Tang","year":"2020","journal-title":"Clin. Translational Med."},{"key":"10.1016\/j.intimp.2022.109040_b0990","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.trsl.2021.05.004","article-title":"Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients","volume":"236","author":"de Gonzalo-Calvo","year":"2021","journal-title":"Translational Res."},{"key":"10.1016\/j.intimp.2022.109040_b0995","doi-asserted-by":"crossref","unstructured":"S. Srivastava, I. Garg, Y. Singh, R. Meena, A.A. Hembrom, N. Ghosh, B. Kumari, V. Kumar, M.R. Eslavath, S. Singh, Evaluation of altered miRNA expression pattern to predict COVID-19 severity, (2021).","DOI":"10.21203\/rs.3.rs-1180630\/v1"},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b1000","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3390\/genes11091002","article-title":"Prediction and analysis of SARS-CoV-2-targeting MicroRNA in human lung epithelium","volume":"11","author":"Chow","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.intimp.2022.109040_b1005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ebiom.2017.11.022","article-title":"MicroRNA-145 impedes thrombus formation via targeting tissue factor in venous thrombosis","volume":"26","author":"Sahu","year":"2017","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b1010","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.3390\/ijms21103598","article-title":"Role of microRNAs in hemophilia and thrombosis in humans","volume":"21","author":"Jankowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/jth.12788","article-title":"MicroRNAs in hemostasis","volume":"13","author":"Teruel-Montoya","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.intimp.2022.109040_b1020","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3389\/fcell.2020.00669","article-title":"Further evidence that microRNAs can play a role in Hemophilia A disease manifestation: F8 gene downregulation by miR-19b-3p and miR-186-5p","volume":"8","author":"Jankowska","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"22","key":"10.1016\/j.intimp.2022.109040_b1025","first-page":"3377","article-title":"Hyperglycemia repression of miR-24 coordinately upregulates endothelial cell expression and secretion of von Willebrand factor","volume":"125","author":"Xiang","year":"2015","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-021-03731-1","article-title":"Role of endothelial miR-24 in COVID-19 cerebrovascular events","volume":"25","author":"Gambardella","year":"2021","journal-title":"Crit. Care"},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b1035","first-page":"18115","article-title":"miR-525-5p inhibits ADAMTS13 and is correlated with Ischemia\/reperfusion injury-induced neuronal cell death","volume":"8","author":"Zhao","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1091\/mbc.e12-07-0519","article-title":"MicroRNA-7\u2013regulated TLR9 signaling\u2013enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3\/Akt pathway","volume":"24","author":"Xu","year":"2013","journal-title":"Mol. Biol. Cell"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1045","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.febslet.2011.01.010","article-title":"MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells","volume":"585","author":"Chen","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.intimp.2022.109040_b1050","article-title":"Platelets miRNA as a prediction marker of thrombotic episodes","volume":"2872507","author":"Bijak","year":"2016","journal-title":"Dis Markers"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-01813-6","article-title":"Let-7a regulates EV secretion and mitochondrial oxidative phosphorylation by targeting SNAP23 in colorectal cancer","volume":"40","author":"Liu","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-95909-4","article-title":"Identification of genes, pathways and transcription factor-miRNA-target gene networks and experimental verification in venous thromboembolism","volume":"11","author":"Su","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b1065","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.1200801","article-title":"Genome-wide analyses of amphioxus microRNAs reveal an immune regulation via miR-92d targeting C3","volume":"190","author":"Yang","year":"2013","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b1070","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1158\/2326-6066.CIR-18-0818","article-title":"MicroRNAs affect complement regulator expression and mitochondrial activity to modulate cell resistance to complement-dependent cytotoxicity","volume":"7","author":"Hillman","year":"2019","journal-title":"Cancer Immunol Res"},{"issue":"14","key":"10.1016\/j.intimp.2022.109040_b1075","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2021770118","article-title":"miR-218-2 regulates cognitive functions in the hippocampus through complement component 3\u2013dependent modulation of synaptic vesicle release","volume":"118","author":"Lu","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b1080","doi-asserted-by":"crossref","first-page":"e012327","DOI":"10.1161\/JAHA.119.012327","article-title":"Increased complement 3 with suppression of miR-145 induces the synthetic phenotype in vascular smooth muscle cells from spontaneously hypertensive rats","volume":"8","author":"Chen","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.intimp.2022.109040_b1085","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.2147\/DMSO.S311725","article-title":"Complement C7 is specifically expressed in mesangial cells and is a potential diagnostic biomarker for diabetic nephropathy and is regulated by miR-494-3p and miR-574-5p","volume":"14","author":"Guo","year":"2021","journal-title":"Diabetes, Metabolic Syndrome and Obesity: Targets Ther."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1090","doi-asserted-by":"crossref","first-page":"232","DOI":"10.4161\/cbt.10.3.12277","article-title":"miRNA-520b and miR-520e sensitize breast cancer cells to complement attack via directly targeting 3\u2032 UTR of CD46","volume":"10","author":"Cui","year":"2010","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/WNR.0b013e32834f4eb4","article-title":"miRNA-155 up-regulation and complement factor H (CFH) deficits in Down\u2019s Syndrome","volume":"23","author":"Li","year":"2012","journal-title":"NeuroReport"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1100","first-page":"105","article-title":"Common micro RNAs (miRNAs) target complement factor H (CFH) regulation in Alzheimer\u2019s disease (AD) and in age-related macular degeneration (AMD)","volume":"3","author":"Lukiw","year":"2012","journal-title":"Int. J. Biochem. Mol. Biol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b1105","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.4049\/jimmunol.1502701","article-title":"Regulation of complement-dependent cytotoxicity by MicroRNAs miR-200b, miR-200c, and miR-217","volume":"196","author":"Hillman","year":"2016","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15476286.2021.2010959","article-title":"Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene","volume":"19","author":"Akula","year":"2022","journal-title":"RNA Biol."},{"key":"10.1016\/j.intimp.2022.109040_b1115","doi-asserted-by":"crossref","first-page":"7733","DOI":"10.2147\/OTT.S187221","article-title":"MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells","volume":"11","author":"Du Meng","year":"2018","journal-title":"OncoTargets Ther."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1120","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/1947601911408888","article-title":"Impaired microRNA processing facilitates breast cancer cell invasion by upregulating urokinase-type plasminogen activator expression","volume":"2","author":"Noh","year":"2011","journal-title":"Genes & cancer"},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b1125","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-14-0938","article-title":"miR340 suppresses the stem-like cell function of glioma-initiating cells by targeting tissue plasminogen activator","volume":"75","author":"Yamashita","year":"2015","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b1130","doi-asserted-by":"crossref","first-page":"e00565","DOI":"10.1128\/MCB.00565-20","article-title":"MicroRNA 617 targeting SERPINE1 inhibited the progression of oral squamous cell carcinoma","volume":"41","author":"Zhao","year":"2021","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1135","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/bjc.2011.520","article-title":"The miR-143\/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancer","volume":"106","author":"Villadsen","year":"2012","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1140","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.ymthe.2018.10.015","article-title":"LDR-induced miR-30a and miR-30b target the PAI-1 pathway to control adverse effects of NSCLC radiotherapy","volume":"27","author":"Park","year":"2019","journal-title":"Mol. Ther."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1145","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1002\/jcp.27108","article-title":"Effect of microRNA-26a on vascular endothelial cell injury caused by lower extremity ischemia\u2013reperfusion injury through the AMPK pathway by targeting PFKFB3","volume":"234","author":"Wu","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b1150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3693","article-title":"MicroRNA-18a inhibits hypoxia-inducible factor 1\u03b1 activity and lung metastasis in basal breast cancers","volume":"16","author":"Krutilina","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1155","first-page":"1","article-title":"The interplay between HIF-1\u03b1 and noncoding RNAs in cancer","volume":"39","author":"Peng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1160","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s10456-018-9600-2","article-title":"miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target","volume":"21","author":"Serocki","year":"2018","journal-title":"Angiogenesis"},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b1165","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.3390\/cancers13123099","article-title":"MicroRNAs Targeting HIF-2\u03b1, VEGFR1 and\/or VEGFR2 as potential predictive biomarkers for VEGFR tyrosine kinase and HIF-2\u03b1 inhibitors in metastatic clear-cell renal cell carcinoma","volume":"13","author":"Kinget","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1170","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/onc.2012.574","article-title":"MicroRNA-145 inhibits the growth, invasion, metastasis and angiogenesis of neuroblastoma cells through targeting hypoxia-inducible factor 2 alpha","volume":"33","author":"Zhang","year":"2014","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b1175","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/gtc.12650","article-title":"MicroRNA-342 inhibits tumor growth via targeting chemokine CXCL12 involved in macrophages recruitment\/activation","volume":"23","author":"Tian","year":"2018","journal-title":"Genes Cells"},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b1180","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3324\/haematol.2013.097675","article-title":"MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cells","volume":"99","author":"Arabanian","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1185","first-page":"2231","article-title":"MicroRNA-31 promotes chondrocyte proliferation by targeting C-X-C motif chemokine ligand 12","volume":"19","author":"Dai","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/08923973.2020.1742734","article-title":"The role of \u03b2-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-\u03baB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients","volume":"42","author":"Mortazavi-Jahromi","year":"2020","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1195","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.pharep.2017.01.021","article-title":"Pharmacological effects of \u03b2-d-mannuronic acid (M2000) on miR-146a, IRAK1, TRAF6 and NF-\u03baB gene expression, as target molecules in inflammatory reactions","volume":"69","author":"Mortazavi-Jahromi","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b1200","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.4161\/rna.21998","article-title":"Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs","volume":"9","author":"Shu","year":"2012","journal-title":"RNA Biol."},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b1205","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1242\/dev.060491","article-title":"Non-cell-autonomous microRNA165 acts in a dose-dependent manner to regulate multiple differentiation status in the Arabidopsis root","volume":"138","author":"Miyashima","year":"2011","journal-title":"Development"},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b1210","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.3390\/ijms22042116","article-title":"MicroRNAs as New Regulators of Neutrophil Extracellular Trap Formation","volume":"22","author":"\u00c1guila","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b1215","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40618-017-0766-z","article-title":"The rs2910164 variant is associated with reduced miR-146a expression but not cytokine levels in patients with type 2 diabetes","volume":"41","author":"Alipoor","year":"2018","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.intimp.2022.109040_b1220","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/916202","article-title":"The functional polymorphisms of miR-146a are associated with susceptibility to severe sepsis in the Chinese population","volume":"2014","author":"Shao","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"40","key":"10.1016\/j.intimp.2022.109040_b1225","doi-asserted-by":"crossref","first-page":"42781","DOI":"10.18632\/oncotarget.5840","article-title":"A functional variant in miR-155 regulation region contributes to lung cancer risk and survival","volume":"6","author":"Xie","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1230","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/gene.2011.84","article-title":"Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene","volume":"13","author":"L\u00f6fgren","year":"2012","journal-title":"Genes Immun."},{"issue":"37","key":"10.1016\/j.intimp.2022.109040_b1235","doi-asserted-by":"crossref","first-page":"60303","DOI":"10.18632\/oncotarget.11206","article-title":"MiR-155 and its functional variant rs767649 contribute to the susceptibility and survival of hepatocellular carcinoma","volume":"7","author":"Ji","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1240","first-page":"1","article-title":"A functional variant rs353292 in the flanking region of miR-143\/145 contributes to the risk of colorectal cancer","volume":"6","author":"Yuan","year":"2016","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b1245","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20204136","article-title":"Association analysis of miRNA-related genetic polymorphisms in miR-143\/145 and KRAS with colorectal cancer susceptibility and survival","volume":"41","author":"Wang","year":"2021","journal-title":"Biosci. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1250","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/imm.12314","article-title":"Transcriptional profiling reveals that C 5a alters micro RNA in brain endothelial cells","volume":"143","author":"Eadon","year":"2014","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11010-011-0752-2","article-title":"miR-27b*, an oxidative stress-responsive microRNA modulates nuclear factor-kB pathway in RAW 264.7 cells","volume":"352","author":"Thulasingam","year":"2011","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2022.109040_b1260","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/504953","article-title":"Insulin regulates glucose consumption and lactate production through reactive oxygen species and pyruvate kinase M2","volume":"2014","author":"Li","year":"2014","journal-title":"Oxid. Med. Cell. Longevity"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1265","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1210\/jc.2009-1128","article-title":"Nuclear factor-\u03baB contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a","volume":"95","author":"Pacifico","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"13","key":"10.1016\/j.intimp.2022.109040_b1270","doi-asserted-by":"crossref","first-page":"5282","DOI":"10.1073\/pnas.0810909106","article-title":"Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals","volume":"106","author":"Bazzoni","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1275","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/hep.23008","article-title":"Up-regulated microRNA-143 transcribed by nuclear factor kappa B enhances hepatocarcinoma metastasis by repressing fibronectin expression","volume":"50","author":"Zhang","year":"2009","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b1280","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jhep.2011.11.017","article-title":"Transcriptional regulation of miR-224 upregulated in human HCCs by NF\u03baB inflammatory pathways","volume":"56","author":"Scisciani","year":"2012","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b1285","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-\u03baB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Iliopoulos","year":"2009","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b1290","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/embor.2012.162","article-title":"Reactive oxygen species regulate ERBB2 and ERBB3 expression via miR-199a\/125b and DNA methylation","volume":"13","author":"He","year":"2012","journal-title":"EMBO Rep."},{"issue":"10","key":"10.1016\/j.intimp.2022.109040_b1295","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.15252\/embr.201540750","article-title":"miR-9-5p suppresses pro-fibrogenic transformation of fibroblasts and prevents organ fibrosis by targeting NOX 4 and TGFBR 2","volume":"16","author":"Fierro-Fern\u00e1ndez","year":"2015","journal-title":"EMBO Rep."},{"issue":"19","key":"10.1016\/j.intimp.2022.109040_b1300","doi-asserted-by":"crossref","first-page":"e00084","DOI":"10.1128\/MCB.00084-18","article-title":"Histone citrullination represses MicroRNA expression, resulting in increased oncogene mRNAs in somatolactotrope cells","volume":"38","author":"DeVore","year":"2018","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1305","doi-asserted-by":"crossref","first-page":"e53791","DOI":"10.1371\/journal.pone.0053791","article-title":"The induction of microRNA-16 in colon cancer cells by protein arginine deiminase inhibition causes a p53-dependent cell cycle arrest","volume":"8","author":"Cui","year":"2013","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b1310","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.3324\/haematol.2014.120295","article-title":"Differential hypoxic regulation of the microRNA-146a\/CXCR4 pathway in normal and leukemic monocytic cells: impact on response to chemotherapy","volume":"100","author":"Spinello","year":"2015","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1315","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/aps.2012.195","article-title":"Hypoxia-regulated microRNAs in human cancer","volume":"34","author":"Shen","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"19","key":"10.1016\/j.intimp.2022.109040_b1320","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1128\/MCB.01276-10","article-title":"MicroRNA-155 promotes resolution of hypoxia-inducible factor 1\u03b1 activity during prolonged hypoxia","volume":"31","author":"Bruning","year":"2011","journal-title":"Mol. Cell. Biol."},{"issue":"13","key":"10.1016\/j.intimp.2022.109040_b1325","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-11-0365","article-title":"Akt2 regulates all Akt isoforms and promotes resistance to hypoxia through induction of miR-21 upon oxygen deprivation","volume":"71","author":"Polytarchou","year":"2011","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1330","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI65344","article-title":"Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis","volume":"123","author":"Chen","year":"2013","journal-title":"J. Clin. Investig."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b1335","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3892\/ijmm.2016.2702","article-title":"Protective effects of miR-25 against hypoxia\/reoxygenation-induced fibrosis and apoptosis of H9c2 cells","volume":"38","author":"Liu","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"9","key":"10.1016\/j.intimp.2022.109040_b1340","first-page":"2069","article-title":"MiR-15a expression analysis in non-small cell lung cancer A549 cells under local hypoxia microenvironment","volume":"21","author":"Jing","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.intimp.2022.109040_b1345","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1089\/ars.2013.5292","article-title":"miR-205 hinders the malignant interplay between prostate cancer cells and associated fibroblasts","volume":"20","author":"Gandellini","year":"2014","journal-title":"Antioxid. Redox Signal."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1350","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2017.04.017","article-title":"Antagonistic effects of p53 and HIF1A on microRNA-34a regulation of PPP1R11 and STAT3 and hypoxia-induced epithelial to mesenchymal transition in colorectal cancer cells","volume":"153","author":"Li","year":"2017","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1355","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1165\/rcmb.2017-0435OC","article-title":"Hypoxia-induced pulmonary hypertension in different mouse strains: relation to transcriptome","volume":"60","author":"Ikeda","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"8","key":"10.1016\/j.intimp.2022.109040_b1360","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/ATVBAHA.112.252619","article-title":"Combination therapy with VELCADE and tPA is neuroprotective in aged rats after stroke and targets miRNA-146a and the toll-like receptor signaling pathway","volume":"32","author":"Zhang","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1365","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/CIRCRESAHA.109.197517","article-title":"MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation","volume":"105","author":"Cheng","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2022.109040_b1370","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3389\/fphar.2020.00047","article-title":"Role of platelet-derived growth factor (PDGF) in asthma as an immunoregulatory factor mediating airway remodeling and possible pharmacological target","volume":"11","author":"Kardas","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1375","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jss.2012.07.063","article-title":"MicroRNA expression following activated protein C treatment during septic shock","volume":"182","author":"Moore","year":"2013","journal-title":"J. Surgical Res."},{"key":"10.1016\/j.intimp.2022.109040_b1380","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.thromres.2017.09.004","article-title":"Plasma let-7i and miR-15a expression are associated with the effect of recombinant tissue plasminogen activator treatment in acute ischemic stroke patients","volume":"158","author":"Xiang","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.intimp.2022.109040_b1385","unstructured":"R. Zarychanski, A. Investigators, Therapeutic anticoagulation in critically ill patients with Covid-19\u2013preliminary report, medRxiv (2021)."},{"key":"10.1016\/j.intimp.2022.109040_b1390","doi-asserted-by":"crossref","unstructured":"A.H. Talasaz, P. Sadeghipour, H. Kakavand, M. Aghakouchakzadeh, B.W. Van Tassell, E. Kordzadeh-Kermani, A. Gheymati, H. Ariannrjad, S.H. Hosseini, S. Jamalkhani, Antithrombotic therapy in COVID-19: systematic summary of ongoing or completed randomized trials, medRxiv (2021).","DOI":"10.1101\/2021.01.04.21249227"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1395","doi-asserted-by":"crossref","first-page":"e241955","DOI":"10.1136\/bcr-2021-241955","article-title":"Double-edged sword effect of anticoagulant in COVID-19 infection","volume":"14","author":"Ohn","year":"2021","journal-title":"BMJ Case Reports CP"},{"key":"10.1016\/j.intimp.2022.109040_b1400","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.thromres.2020.08.010","article-title":"Heparin failure and COVID-19: should we explore other anticoagulants? An observational report regarding in-vitro recovery of anticoagulant action in COVID-19 patients in intensive care","volume":"195","author":"Thomas","year":"2020","journal-title":"Thromb. Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1405","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11239-020-02145-0","article-title":"Heparin resistance in COVID-19 patients in the intensive care unit","volume":"50","author":"White","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1410","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.hrtlng.2020.10.009","article-title":"Pattern of anticoagulation prescription for patients with Covid-19 acute respiratory distress syndrome admitted to ICU. Does it impact outcome?","volume":"50","author":"Nadeem","year":"2021","journal-title":"Heart Lung"},{"issue":"6367","key":"10.1016\/j.intimp.2022.109040_b1415","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.aam8897","article-title":"Host DNases prevent vascular occlusion by neutrophil extracellular traps","volume":"358","author":"Jim\u00e9nez-Alc\u00e1zar","year":"2017","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1420","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/STROKEAHA.117.019896","article-title":"Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke","volume":"49","author":"Ducroux","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/j.intimp.2022.109040_b1425","article-title":"Proteome profiling of recombinant DNase therapy in reducing NETs and aiding recovery in COVID-19 patients","volume":"100113","author":"Fisher","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.intimp.2022.109040_b1430","unstructured":"N. de Buhr, A.C. Parplys, M. Schroeder, T. Henneck, B. Schaumburg, S. Stanelle-Bertram, D. Jarczak, A. Nierhaus, J. Hiller, S. Peine, Impaired Degradation of Neutrophil Extracellular Traps: A Possible Severity Factor of Elderly Male COVID-19 Patients, J. Innate Immunity 1-16."},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b1435","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1159\/000363699","article-title":"Novel role of the antimicrobial peptide LL-37 in the protection of neutrophil extracellular traps against degradation by bacterial nucleases","volume":"6","author":"Neumann","year":"2014","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.intimp.2022.109040_b1440","doi-asserted-by":"crossref","unstructured":"T.M. Clausen, D.R. Sandoval, C.B. Spliid, J. Pihl, H.R. Perrett, C.D. Painter, A. Narayanan, S.A. Majowicz, E.M. Kwong, R.N. McVicar, SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2, Cell 183(4) (2020) 1043-1057. e15.","DOI":"10.1016\/j.cell.2020.09.033"},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1445","first-page":"489","article-title":"SNP-CRISPR: a web tool for SNP-specific genome editing, G3: Genes","volume":"10","author":"Chen","year":"2020","journal-title":"Genomes, Genetics"},{"key":"10.1016\/j.intimp.2022.109040_b1450","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3389\/fcvm.2021.644095","article-title":"COVID-19 in relation to hyperglycemia and diabetes mellitus","volume":"8","author":"Al-kuraishy","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.intimp.2022.109040_b1455","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fmed.2021.644295","article-title":"COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with type II diabetes mellitus: the anti-inflammatory role of metformin","volume":"8","author":"Al-Kuraishy","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.intimp.2022.109040_b1460","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102008","article-title":"Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects","volume":"67","author":"Al-Kuraishy","year":"2021","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2022.109040_b1465","first-page":"1","article-title":"The Prospective Effect of Allopurinol on the Oxidative Stress Index and Endothelial Dysfunction in Covid-19","author":"Al-Kuraishy","year":"2022","journal-title":"Inflammation"},{"key":"10.1016\/j.intimp.2022.109040_b1470","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108450","article-title":"The first case of COVID-19 treated with the complement C3 inhibitor AMY-101","volume":"215","author":"Mastaglio","year":"2020","journal-title":"Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109040_b1475","doi-asserted-by":"crossref","DOI":"10.1016\/j.imbio.2020.152001","article-title":"Endothelial injury and thrombotic microangiopathy in COVID-19: treatment with the lectin-pathway inhibitor narsoplimab","volume":"225","author":"Rambaldi","year":"2020","journal-title":"Immunobiology"},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b1480","first-page":"S144","article-title":"Anti-histamines and Covid-19: Hype or Hope","volume":"71","author":"Al-Kuraishy","year":"2021","journal-title":"J. Pakistan Med. Assoc."},{"key":"10.1016\/j.intimp.2022.109040_b1485","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174196","article-title":"Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of Covid-19: The enigmatic entity","volume":"904","author":"Al-Kuraishy","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109040_b1490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114431","article-title":"PDE4 inhibition as a therapeutic strategy for improvement of pulmonary dysfunctions in Covid-19 and cigarette smoking","volume":"185","author":"Lugnier","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"12","key":"10.1016\/j.intimp.2022.109040_b1495","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1007\/s11033-021-06770-7","article-title":"Niclosamide for Covid-19: bridging the gap","volume":"48","author":"Al-Kuraishy","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.intimp.2022.109040_b1500","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fphar.2021.642822","article-title":"Pleiotropic effects of tetracyclines in the management of COVID-19: emerging perspectives","volume":"12","author":"Al-Kuraishy","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109040_b1505","first-page":"S127","article-title":"Colchicine in the management of Covid-19: With or lieu of evidence","author":"Al-Kuraishy","year":"2021","journal-title":"J. Pakistan Med. Assoc."},{"issue":"11","key":"10.1016\/j.intimp.2022.109040_b1510","doi-asserted-by":"crossref","first-page":"4161","DOI":"10.1007\/s11010-021-04232-z","article-title":"The potential role of neopterin in Covid-19: a new perspective","volume":"476","author":"Al-Kuraishy","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.intimp.2022.109040_b1515","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.649128","article-title":"The looming effects of estrogen in Covid-19: a rocky rollout","volume":"8","author":"Al-Kuraishy","year":"2021","journal-title":"Frontiers in Nutrition"},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b1520","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.pharep.2017.04.015","article-title":"Introduction of \u03b2-d-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property based on COX-1\/COX-2 activity and gene expression","volume":"69","author":"Mirshafiey","year":"2017","journal-title":"Pharmacol. Rep."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1525","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/1872213X12666180607121809","article-title":"Evaluation of the effect of \u03b1-L-guluronic acid (G2013) on COX-1, COX-2 activity and gene expression for introducing this drug as a novel NSAID with immunomodulatory property","volume":"12","author":"Mirshafiey","year":"2018","journal-title":"Recent Pat. Inflammation Allergy Drug Discovery"},{"key":"10.1016\/j.intimp.2022.109040_b1530","unstructured":"M. Aslani, A. Ahmadzadeh, Z. Aghazadeh, M. Zaki-Dizaji, L. Sharifi, M. Hosseini, A. Mirshafiey, Influence of \u03b2-D-mannuronic acid, as a new member of non-steroidal anti-inflammatory drugs family, on expression pattern of chemokines and their receptors in rheumatoid arthritis, Current drug discovery technologies (2019)."},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1535","first-page":"69","article-title":"The situation of chemokine ligands and receptors gene expression, following the oral administration of drug mannuronic acid in rheumatoid arthritis patients, recent patents on inflammation & allergy","volume":"14","author":"Aslani","year":"2020","journal-title":"Drug Discovery"},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1540","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1177\/1721727X16660093","article-title":"Inhibitory effect of G2013 molecule as a novel immunomodulatory agent, on miR-155 gene expression in HEK-Blue hTLR4 cell line","volume":"14","author":"Mortazavi Jahromi","year":"2016","journal-title":"Eur. J. Inflamm."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1545","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ddr.21619","article-title":"Immunopharmacological effect of \u03b2-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients","volume":"81","author":"Mortazavi-Jahromi","year":"2020","journal-title":"Drug Dev. Res."},{"issue":"2","key":"10.1016\/j.intimp.2022.109040_b1550","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4081\/reumatismo.2020.1235","article-title":"Effects of mannuronic acid (M2000) on gene expression profile of signal transducer and activator of transcription proteins (STATs) in rheumatoid arthritis patients","volume":"72","author":"Gaafar","year":"2020","journal-title":"Reumatismo"},{"issue":"1","key":"10.1016\/j.intimp.2022.109040_b1555","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12026-018-9042-3","article-title":"Assessment of immunological profile in ankylosing spondylitis patients following a clinical trial with guluronic acid (G2013), as a new NSAID with immunomodulatory properties","volume":"67","author":"Mortazavi-Jahromi","year":"2019","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b1560","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s10787-018-00557-2","article-title":"International multicenter randomized, placebo-controlled phase III clinical trial of \u03b2-d-mannuronic acid in rheumatoid arthritis patients","volume":"27","author":"Rezaieyazdi","year":"2019","journal-title":"Inflammopharmacology"},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b1565","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/13813455.2018.1481094","article-title":"Anti-diabetic effect of \u03b2-D-mannuronic acid (M2000) as a novel NSAID with immunosuppressive property on insulin production, blood glucose, and inflammatory markers in the experimental diabetes model","volume":"125","author":"Mortazavi-Jahromi","year":"2019","journal-title":"Arch. Physiol. Biochem."},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1570","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s10787-018-0475-z","article-title":"A phase I\/II randomized, controlled, clinical trial for assessment of the efficacy and safety of \u03b2-D-mannuronic acid in rheumatoid arthritis patients","volume":"26","author":"Ahmadi","year":"2018","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.intimp.2022.109040_b1575","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.intimp.2018.01.003","article-title":"Effects of guluronic acid (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathway","volume":"55","author":"Mortazavi-Jahromi","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2022.109040_b1580","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopha.2018.02.059","article-title":"Oral administration effects of \u03b2-D-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis","volume":"100","author":"Fattahi","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b1585","first-page":"530","article-title":"Modification of sexual hormones in rheumatoid arthritis patients by M2000 (\u03b2-d-mannuronic acid) as a Novel NSAID with immunosuppressive property, Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune","volume":"18","author":"Jahanbakhshi","year":"2018","journal-title":"Endocrine & Metabolic Disorders)"},{"issue":"8","key":"10.1016\/j.intimp.2022.109040_b1590","first-page":"PI53-PI63","article-title":"M2000: a revolution in pharmacology","volume":"11","author":"Mirshafiey","year":"2005","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2022.109040_b1595","first-page":"1","article-title":"Evaluating mannuronic acid effect on gene expression profile of inflammatory mediators in rheumatoid arthritis patients","author":"Omidian","year":"2021","journal-title":"Iranian J. Allergy, Asthma Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b1600","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2174\/1570163816666190620113320","article-title":"The oral administration effect of drug mannuronic acid (M2000) on gene expression of matrix and tissue inhibitor of metalloproteinases in rheumatoid arthritis patients","volume":"17","author":"Gaafar","year":"2020","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.intimp.2022.109040_b1605","doi-asserted-by":"crossref","unstructured":"S.S. Mortazavi-Jahromi, S. Alizadeh, M.H. Javanbakht, A. Mirshafiey, Anti-Diabetic and Angio-Protective Effect of Guluronic Acid (G2013) as a New Nonsteroidal Anti-Inflammatory Drug in the Experimental Model of Diabetes, Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets-Immune, Endocrine & Metabolic Disorders) 20(3) (2020) 446-452.","DOI":"10.2174\/1871530319666191016103918"},{"issue":"3","key":"10.1016\/j.intimp.2022.109040_b1610","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2174\/1570163815666180515122834","article-title":"Effect of \u03b2-D-mannuronic acid (M2000) on oxidative stress enzymes\u2019 gene using healthy donor peripheral blood mononuclear cells for evaluating the anti-aging property","volume":"16","author":"Taeb","year":"2019","journal-title":"Curr. Drug Discov. Technol."},{"key":"10.1016\/j.intimp.2022.109040_b1615","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.biopha.2017.03.066","article-title":"An in vitro evaluation of anti-aging effect of guluronic acid (G2013) based on enzymatic oxidative stress gene expression using healthy individuals PBMCs","volume":"90","author":"Taeb","year":"2017","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b1620","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/08923973.2018.1455209","article-title":"Cardioprotective effect of \u03b2-d-mannuronic acid (M2000) as a novel NSAID on gene expression of oxLDL scavenger receptors in the experimental diabetic model","volume":"40","author":"Mortazavi-Jahromi","year":"2018","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"4","key":"10.1016\/j.intimp.2022.109040_b1625","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2478\/jomb-2018-0009","article-title":"Profiles of circulating miRNAs following metformin treatment in patients with type 2 diabetes","volume":"37","author":"Demirsoy","year":"2018","journal-title":"J. Medical Biochem."},{"issue":"5","key":"10.1016\/j.intimp.2022.109040_b1630","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/1074248420922793","article-title":"A MicroRNA signature in acute coronary syndrome patients and modulation by colchicine","volume":"25","author":"Barraclough","year":"2020","journal-title":"J. Cardiovasc. Pharmacol. Therapeutics"},{"key":"10.1016\/j.intimp.2022.109040_b1635","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.12659\/MSM.909800","article-title":"Doxycycline attenuates atrial remodeling by interfering with microRNA-21 and downstream phosphatase and tensin homolog (PTEN)\/phosphoinositide 3-kinase (PI3K) signaling pathway","volume":"24","author":"Zhang","year":"2018","journal-title":"Medical Science Monitor: Int. Medical J. Experimental Clin. Res."},{"issue":"18","key":"10.1016\/j.intimp.2022.109040_b1640","doi-asserted-by":"crossref","first-page":"1904040","DOI":"10.1002\/adma.201904040","article-title":"Exosomes and nanoengineering: a match made for precision therapeutics","volume":"32","author":"Tran","year":"2020","journal-title":"Adv. Mater."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922005240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:42:09Z","timestamp":1761586929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922005240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":328,"alternative-id":["S1567576922005240"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109040","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis\/thromboinflammation","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109040"}}